(259 days)
MedGyn's Digital Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to assist doctors in diagnosing abnormalities such as lesions or cancer, and selecting areas for biopsy. The images from the Digital Video Colposcope are to be viewed on a color monitor. The Digital Video Colposcope is intended for use in hospitals, clinics, and doctors' offices.
The MedGyn Digital Video Colposcope, models AL-106, AL-106SA and AL-106B (collectively, the "MedGyn Colposcope"), has the same application as traditional colposcopes. However, while traditional optical colposcopes use binocular eyepieces for magnification, the MedGyn Colposcope uses electronic imaging technology to assist doctors in reviewing, checking, analyzing, and diagnosing abnormalities or lesions of the vulva, vagina, cervix and external genitalia. It is designed to be used in hospitals, doctors' offices and clinics by qualified or trained personnel.
The MedGyn Colposcope is an active, non-contact examination device. It uses a HAD CCD color digital video camera with a digital magnification of up to 40x (or only 32x for model AL-106B), a field of view of 52° at 1x and 2° at 32X, and a green filtered light source. The camera is attached to a floor stand; model AL-106SA has a swing-arm floor stand. A cable coming from the bottom of the floor stand connects to the signal conversion box. The customer then uses the composite video cable or the s-video cable to connect a commercially available monitor to the conversion signal box.
Tissue is magnified and viewed on the doctor's own computer monitor (not included with device). Both the doctor and the patient can observe the monitor's screen, thus helping the doctor explain the abnormalities and the suggested treatments to the patient, and allowing patient to see the abnormalities for herself and better understand her medical situation.
The provided document is a 510(k) summary for the MedGyn Digital Video Colposcope, which outlines its substantial equivalence to a predicate device. This type of submission relies on non-clinical performance testing rather than clinical studies to demonstrate safety and effectiveness. Therefore, the device does not have "acceptance criteria" in the sense of a clinical trial's endpoint metrics, nor does it present a study that proves the device meets such criteria for diagnostic accuracy or clinical outcomes.
Instead, the document focuses on demonstrating that the MedGyn Colposcope meets relevant performance standards and technical specifications that are comparable to a legally marketed predicate device.
Here's an analysis based on the provided text, addressing your points where applicable:
1. Table of Acceptance Criteria and Reported Device Performance
Since this is a non-clinical submission, "acceptance criteria" are tied to engineering specifications and compliance with voluntary performance standards. There are no diagnostic "performance" metrics (like sensitivity, specificity) derived from a clinical application in this document.
| Metric/Standard | Acceptance Criteria (Implied/Stated) | Reported Device Performance |
|---|---|---|
| Voluntary Performance Standards | Compliance with recognized international standards for medical electrical equipment and endoscopes. | - IEC60601-1:1988 + A1:1001 + A2: 1995 (Medical Electrical Equipment Safety) - IEC60601-1-1:2000 (Medical Electrical Equipment Safety - Collateral Standard: Medical Electrical Systems) - IEC60601-1-2:2007 (Medical Electrical Equipment EMC) - ISO 8600-3:1997 (Endoscopes - Field of View and Direction of View) - ISO 8600-5:2005 (Endoscopes - Optical Resolution) |
| On-Axis Resolution | (Implied: Sufficient for intended use, comparable to predicate, or within established industry benchmarks for colposcopes) | 11.31 line-pairs/mm |
| On-Axis Angular Resolution | (Implied: Sufficient for intended use, comparable to predicate, or within established industry benchmarks for colposcopes) | 0.02534 degrees |
| Geometrical Distortion | ≤ 3% (explicitly stated as acceptable) | - AL-106B = +1% - AL-106 & AL-106SA = +2.49% |
| Thermal Safety | (Implied: Minimal temperature rise, meeting safety standards) | From 200mm, temperature rise of only 0.20 Celsius after 30 minutes continuous working. |
| Magnification | Up to 40x digital (AL-106, AL-106SA), up to 32x digital (AL-106B) and 1-36x optical (AL-106, AL-106SA), 1-18x optical (AL-106B) | AL-106, AL-106SA: Digital 1-40x, Optical 1-36x AL-106B: Digital 1-32x, Optical 1-18x |
| Field of View (200mm WD) | (Implied: Sufficient for intended use, comparable to predicate) | At 1x >= 195mm (52°), At 32x >= 6.978mm (2°) |
| Depth of View | (Implied: Sufficient for intended use, comparable to predicate) | 5mm~120mm |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: Not applicable in the context of clinical "test sets" for diagnostic accuracy. The testing mentioned in Section 7 ("Discussion of Non-Clinical Tests Performed") refers to engineering and bench testing of the device itself (e.g., resolution targets, distortion grids, temperature sensors) rather than patient data.
- Data Provenance: Not applicable. The "data" are measurements and compliance certificates from device testing, not patient data from a specific country or collected retrospectively/prospectively.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications
- Number of Experts: Not applicable. This submission does not involve a clinical test set requiring expert-established ground truth for diagnostic accuracy since it's a non-clinical performance evaluation focused on engineering specifications.
4. Adjudication Method for the Test Set
- Adjudication Method: Not applicable for the same reason as point 3.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
- MRMC Study: No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. This type of study assesses how human readers' performance changes with or without AI assistance, which is beyond the scope of a 510(k) summary relying on non-clinical testing to demonstrate substantial equivalence for a colposcope that is essentially an imaging tool, not a diagnostic AI.
6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study
- Standalone Study: No. This device is a colposcope, an imaging instrument used by a human clinician. It does not incorporate an independent algorithm for diagnosis that would typically warrant a standalone performance evaluation.
7. Type of Ground Truth Used
- Type of Ground Truth: Not applicable in the clinical sense. The "ground truth" for the non-clinical tests involved objective physical measurements and compliance verification against established engineering standards (e.g., resolution charts, distortion grids, temperature probes).
8. Sample Size for the Training Set
- Sample Size: Not applicable. This device does not use machine learning or AI that would require a "training set" of data.
9. How the Ground Truth for the Training Set Was Established
- How Ground Truth for Training Set Was Established: Not applicable, as there is no training set for this device.
In summary: The K122973 submission for the MedGyn Digital Video Colposcope is a demonstration of substantial equivalence based on non-clinical performance testing and compliance with voluntary international standards. It explicitly states "Discussion of Clinical Tests Performed: Not Applicable." This means no clinical studies were conducted, and therefore, no "acceptance criteria" related to diagnostic accuracy or clinical outcomes were evaluated using patient data or expert ground truth. The acceptance criteria are engineering specifications and safety standards defined by regulatory bodies and consensus organizations.
{0}------------------------------------------------
K122973 Page 1 of 4
510(k) Summary # K122973 MedGyn Products, Inc.
510(k) Summary
JUN 1 2 2013
1. Submitter's Identification:
MedGyn Products, Inc. 100 W. Industrial Road Addison, IL 60101 Phone: 630.627.4105 Fax: 630.627.0127 Attn: Lakshman Agadi, President
Attorney Contact:
Intellectual Property Law Group LLP 12 South First Street, 12th Floor San Jose, CA 95113 Phone: (408) 286-8933 Fax: (408) 286-8932 Attn: Stephanie Blair, Attorney
Date Summary Prepared: June 10, 2013
2. Name of Device.
Device Name:
AL-106, AL-106SA and AL-106B MedGyn Digital Video Colposcope
Trade/ Proprietary Name: AL-106, AL-106SA and AL-106B MedGyn Digital Video Colposcope
Common Name:
Colposcope
Classification:
Class II 21 CFR884.1630 Colposcope 85HEX
3. Predicate Device Information
Identification of Legally Marketed Device with Which We Claim Substantial Equivalence (Predicate Device):
The Goldway Digital Video Colposcope Imaging System, model number SLC-2000, manufactured by Goldway, 510(k) number: K021153.
Note that the Goldway Digital Video Colposcope Imaging System included an LCD screen for viewing the images from the colposcope, but the MedGyn Digital Video Colposcope does not include a monitor.
{1}------------------------------------------------
4. Device Description
a. Executive Summary:
The MedGyn Digital Video Colposcope, models AL-106, AL-106SA and AL-106B (collectively, the "MedGyn Colposcope"), has the same application as traditional colposcopes. However, while traditional optical colposcopes use binocular eyepieces for magnification, the MedGyn Colposcope uses electronic imaging technology to assist doctors in reviewing, checking, analyzing, and diagnosing abnormalities or lesions of the vulva, vagina, cervix and external genitalia. It is designed to be used in hospitals, doctors' offices and clinics by qualified or trained personnel.
The MedGyn Colposcope is an active, non-contact examination device. It uses a HAD CCD color digital video camera with a digital magnification of up to 40x (or only 32x for model AL-106B), a field of view of 52° at 1x and 2° at 32X, and a green filtered light source. The camera is attached to a floor stand; model AL-106SA has a swing-arm floor stand. A cable coming from the bottom of the floor stand connects to the signal conversion box. The customer then uses the composite video cable or the s-video cable to connect a commercially available monitor to the conversion signal box.
Tissue is magnified and viewed on the doctor's own computer monitor (not included with device). Both the doctor and the patient can observe the monitor's screen, thus helping the doctor explain the abnormalities and the suggested treatments to the patient, and allowing patient to see the abnormalities for herself and better understand her medical situation.
b. Technical Description:
The MedGyn Colposcope has the following technical features:
- . 1/4" HAD CCD digital video camera
- Fast auto focus, and manual focus .
- Digital Magnification 1
40x (For AL-106B model, digital magnification is 132x) . - Optical Magnification 1
36x (For AL-106B model, optical magnification is 118x) ● - . Double circular LED group light source
- 3 grade green filter function .
- . S-video output
- . Image freeze control
- Field of View (at a working distance of 200mm) .
- o At 1X >= 195mm (52°)
- o At 32X >= 6.978mm (20)
- . Depth of view: 5mm~120mm
- Magnification and acetic acid reaction timing display .
- . Multi-function button control which allows for direct and convenient control of operations such as magnification, zoom, focus, freeze and green filter.
5. Intended Use:
MedGyn's Digital Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to assist doctors in diagnosing abnormalities such as lesions or cancer, and selecting areas for biopsy. The images from the Digital Video
{2}------------------------------------------------
510(k) Summary # K122973 MedGyn Products, Inc.
Colposcope are to be viewed on a color monitor. The Digital Video Colposcope is intended for use in hospitals, clinics, and doctors' offices.
6. Comparison to Predicate Device:
Both the predicate device, the Goldway SLC-2000 Digital Video Colposcope Imaging System, and the MedGyn Colposcope have the same intended use, which is to provide an imaging system that facilitates direct viewing and imaging of the tissues of the vagina, cervix and external genitalia.
The MedGyn Colposcope is very similar to the predicate device, with only slight differences in the CCD chip, resolution, illumination, focal length, depth of view and field of view. The MedGyn Colposcope allows for a wider direction of view and a higher optical magnification than Goldway's colposcope. Both colposcopes use LED light and a green filter, and are configured to provide the necessary working distance and magnification for patient observation.
The Goldway and MedGyn devices are both self-contained, stand-alone units incorporating light, power and video into a compact system. Both devices are offered with similar floor stands, but MedGyn also offers a swing-arm stand (model AL-106SA). However, note that the Goldway Digital Video Colposcope Imaging System included an LCD screen for viewing the images from the colposcope, but the MedGyn Digital Video Colposcope does not include a monitor.
7. Discussion of Non-Clinical Tests Performed:
The following voluntary Performance Standards were met:
- . IEC60601-1:1988 + A1:1001 + A2: 1995 (MEDICAL ELECTRICAL EQUIPMENT PART : GENERAL REQUIREMENTS FOR SAFETY)
- IEC60601-1-1:2000 (MEDICAL ELECTRICAL EQUIPMENT PART 1-1: GENERAL . REQUIREMENTS FOR SAFETY - COLLATERAL STANDARD: SAFETY REQUIREMENTS FOR MEDICAL ELECTRICAL SYSTEMS)
- IEC60601-1-2:2007 (MEDICAL ELECTRICAL EQUIPMENT PART I-2: GENERAL . REQUIREMENTS FOR SAFETY -COLLATERAL STANDARD: ELECTROMAGNETIC COMPATIBILITY-REQUIREMENTS AND TESTS)
- ISO 8600-3:1997 (MEDICAL ENDOSCOPES AND ENDOSCOPIC ACCESSORIES --. PART 3: DETERMINATION OF FIELD OF VIEW AND DIRECTION OF VIEW OF ENDOSCOPES WITH OPTICS)
- . ISO 8600-5:2005 (MEDICAL ENDOSCOPES AND ENDOTHERAPY DEVICES --PART 5: DETERMINATION OF OPTICAL RESOLUTION OF RIGID ENDOSCOPES WITH OPTICS)
Resolution Information:
MedGyn's Digital Video Colposcopes have the following resolution:
- On-Axis Resolution: i = = = = = = = 11.31 line-pairs/mm ।
- 0.02534 degrees On-Axis Angular Resolution: ।
{3}------------------------------------------------
510(k) Summary # K 122973 MedGyn Products, Inc.
Distortion Information (note - a geometrical distortion of ≤ 3% is acceptable):
- AL-106B = +1% ..
- AL-106 & AL-106SA = +2.49% -
Thermal Safety Testing Information:
- After working continuously for 30 minutes, from a distance of 200mm, the temperature of the test surface rose by only 0.20 Celsius.
8. Discussion of Clinical Tests Performed:
Not Applicable.
9. Conclusion
The MedGyn Colposcope has equivalent indications for use and principals of operation as compared to the predicate device. The differing features of the MedGyn Colposcope do not affect the use, safety or effectiveness of the device. The MedGyn Colposcope is substantially equivalent to the Goldway Digital Video Colposcope Imaging System.
{4}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like figure with three curved lines representing its body and wings. The logo is surrounded by text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
June 12, 2013
MedGyn Products, Inc. % Ms. Stephanie Blair Attorney Intellectual Property Law Group, LLP 12 South First Street, 12th Floor SAN JOSE CA 95113
Re: K122973
Trade/Device Name: AL-106, AL-106SA, AL-106B MedGyn Digital Video Colposcope Regulation Number: 21 CFR$ 884.1630 Regulation Name: Colposcope Regulatory Class: II Product Code: HEX Dated: May 23, 2013 Received: May 29, 2013
Dear Ms. Blair:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of
{5}------------------------------------------------
Page 2 - Ms. Stephanie Blair
medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Herbert P. Lerner -S
| for |
|---|
| Benjamin R. Fisher, Ph.D. |
| Director |
| Division of Reproductive, Gastro-Renal, |
| and Urological Devices |
| Office of Device Evaluation |
| Center for Devices and Radiological Health |
Enclosure
{6}------------------------------------------------
Indications for Use
510(k) Number (if known):
Device Name: AL-106, AL-106SA, AL-106B MedGyn Digital Video Colposcope
Indications For Use:
MedGyn's Digital Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to assist doctors in diagnosing abnormalities such as lesions or cancer, and selecting areas for biopsy. The images from the Digital Video Colposcope are to be viewed on a color monitor. The Digital Video Colposcope is intended for use in hospitals, clinics, and doctor's offices.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Herbert | Parner -S
Page 1 of
(Division Sign-Off) Division of Reproductive, Gastro-Renal, and Urological Devices K122973 510(k) Number
§ 884.1630 Colposcope.
(a)
Identification. A colposcope is a device designed to permit direct viewing of the tissues of the vagina and cervix by a telescopic system located outside the vagina. It is used to diagnose abnormalities and select areas for biopsy. This generic type of device may include a light source, cables, and component parts.(b)
Classification. Class II (special controls). The device, when it is a standard colposcope (or colpomicroscope) that uses only a white light source, does not use filters other than a green filter, does not include image analysis software, and is not smartphone-based, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.